Compare Natera Inc. Common Stock (NTRA) vs Financial Select Sector SPDR Fund (XLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Financial Select Sector SPDR Fund — how do they compare? Natera Inc. Common Stock trades at $392.78 (market cap $57.03B), while Financial Select Sector SPDR Fund trades at $54.93 (market cap $51.80B). The key difference: Natera Inc. Common Stock and Financial Select Sector SPDR Fund are close in size by market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Financial Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Financial Select Sector SPDR Fund for 104 Days on average.
| NTRA | XLF | |
|---|---|---|
Market Cap | $57.03B | $51.80B |
Volume | 1,131,157 | 44,049,658 |
Sector | Health | — |
52-Week High | $425.64 | $58.55 |
52-Week Low | $179.42 | $47.80 |
Typical Hold Time | 0 Days | 104 Days |
Enterprise Value | $56.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
XLF trades at $54.82, down 0.42% with a mixed technical outlook showing bullish moving averages but neutral oscillators. The ETF faces sector headwinds as financial stocks lag the broader market despite rising bank profits. Recent Federal Reserve stress test changes and interest rate hikes create both opportunities and challenges for financial sector performance.
The financial sector ETF benefits from rising interest rates but faces regulatory uncertainty and market underperformance risks. Key catalysts include Fed policy decisions and bank earnings, while political gridlock may limit legislative impacts on financial regulations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Financial Select Sector SPDR Fund
The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →
